Abdel-Baki, A., Ouellet-Plamondon, C., Salvat, É., Grar, K., & Potvin, S. (2017). Symptomatic and functional outcomes of substance use disorder persistence 2 years after admission to a first-episode psychosis program. Psychiatry Research, 247, 113–119.

Article  PubMed  Google Scholar 

Amare, A. T., Vaez, A., Hsu, Y. H., Direk, N., Kamali, Z., Howard, D. M., ... & Hartman, C. A. (2020). Bivariate genome-wide association analyses of the broad depression phenotype combined with major depressive disorder, bipolar disorder or schizophrenia reveal eight novel genetic loci for depression. Molecular psychiatry, 25(7), 1420–1429.

Arnold, P. D., Askland, K. D., Barlassina, C., Bellodi, L., Bienvenu, O. J., Black, D., ... & Zai, G. (2018). Revealing the complex genetic architecture of obsessive-compulsive disorder using meta-analysis. Molecular psychiatry, 23(5), 1181–1181.

Asaad, T. A., Ghanem, M. H., Samee, A. M. A., & El-Habiby, M. M. (2011). Sleep profile in patients with chronic opioid abuse: A polysomnographic evaluation in an Egyptian sample. Addictive Disorders & Their Treatment, 10(1), 21–28.

Article  Google Scholar 

Barkus, E. (2016). High-potency cannabis increases the risk of psychosis. BMJ Ment Health, 19(2), 54–54.

Google Scholar 

Battle, D. E. (2013). Diagnostic and statistical manual of mental disorders (DSM). In Codas, 25(2), 191–192.

Google Scholar 

Burgess, S., & Thompson, S. G. (2017). Interpreting findings from Mendelian randomization using the MR-Egger method. European Journal of Epidemiology, 32, 377–389.

Article  PubMed  PubMed Central  Google Scholar 

Burgess, S., Davies, N. M., & Thompson, S. G. (2016). Bias due to participant overlap in two-sample Mendelian randomization. Genetic Epidemiology, 40(7), 597–608.

Article  PubMed  PubMed Central  Google Scholar 

Cardno, A. G., & Owen, M. J. (2014). Genetic relationships between schizophrenia, bipolar disorder, and schizoaffective disorder. Schizophrenia Bulletin, 40(3), 504–515.

Article  PubMed  PubMed Central  Google Scholar 

Carter, A. R., Sanderson, E., Hammerton, G., Richmond, R. C., Davey Smith, G., Heron, J., ... & Howe, L. D. (2021). Mendelian randomisation for mediation analysis: Current methods and challenges for implementation. European journal of epidemiology, 36(5), 465–478.

Chambers, R. A., Krystal, J. H., & Self, D. W. (2001). A neurobiological basis for substance abuse comorbidity in schizophrenia. Biological Psychiatry, 50(2), 71–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang, K. C., Lee, K. Y., Lu, T. H., Hwang, J. S., Lin, C. N., Ting, S. Y., ... & Wang, J. D. (2019). Opioid agonist treatment reduces losses in quality of life and quality-adjusted life expectancy in heroin users: Evidence from real world data. Drug and alcohol dependence, 201, 197–204.

Chiappelli, J., Chen, S., Hackman, A., & Hong, L. E. (2018). Evidence for differential opioid use disorder in schizophrenia in an addiction treatment population. Schizophrenia Research, 194, 26–31.

Article  PubMed  Google Scholar 

Choi, K. W., Chen, C. Y., Stein, M. B., Klimentidis, Y. C., Wang, M. J., Koenen, K. C., & Smoller, J. W. (2019). Assessment of bidirectional relationships between physical activity and depression among adults: A 2-sample mendelian randomization study. JAMA Psychiatry, 76(4), 399–408.

Article  PubMed  PubMed Central  Google Scholar 

Clark, S. D., & Abi-Dargham, A. (2019). The role of dynorphin and the kappa opioid receptor in the symptomatology of schizophrenia: A review of the evidence. Biological Psychiatry, 86(7), 502–511.

Article  CAS  PubMed  Google Scholar 

Clark, S. D., Van Snellenberg, J. X., Lawson, J. M., & Abi-Dargham, A. (2020). Opioid antagonists are associated with a reduction in the symptoms of schizophrenia: A meta-analysis of controlled trials. Neuropsychopharmacology, 45(11), 1860–1869.

Article  PubMed  PubMed Central  Google Scholar 

Davis, M. A., Lin, L. A., Liu, H., & Sites, B. D. (2017). Prescription opioid use among adults with mental health disorders in the United States. The Journal of the American Board of Family Medicine, 30(4), 407–417.

Article  PubMed  Google Scholar 

Degenhardt, L., Grebely, J., Stone, J., Hickman, M., Vickerman, P., Marshall, B. D., ... & Larney, S. (2019). Global patterns of opioid use and dependence: Harms to populations, interventions, and future action. The Lancet, 394(10208), 1560–1579.

Dijkstra, B. A., De Jong, C. A., Krabbe, P. F., & van der Staak, C. P. (2008). Prediction of abstinence in opioid-dependent patients. Journal of Addiction Medicine, 2(4), 194–201.

Article  PubMed  Google Scholar 

Dolsen, E. A., & Harvey, A. G. (2017). Life-time history of insomnia and hypersomnia symptoms as correlates of alcohol, cocaine and heroin use and relapse among adults seeking substance use treatment in the United States from 1991 to 1994. Addiction, 112(6), 1104–1111.

Article  PubMed  PubMed Central  Google Scholar 

Dowell, D., Arias, E., Kochanek, K., Anderson, R., Guy, G. P., Losby, J. L., & Baldwin, G. (2017). Contribution of opioid-involved poisoning to the change in life expectancy in the United States, 2000–2015. JAMA, 318(11), 1065–1067.

Article  PubMed  PubMed Central  Google Scholar 

Dunn, K. E., Saulsgiver, K. A., Miller, M. E., Nuzzo, P. A., & Sigmon, S. C. (2015). Characterizing opioid withdrawal during double-blind buprenorphine detoxification. Drug and Alcohol Dependence, 151, 47–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Farrell, M., Boys, A., Bebbington, P., Brugha, T., Coid, J., Jenkins, R., ... & Taylor, C. (2002). Psychosis and drug dependence: Results from a national survey of prisoners. The British Journal of Psychiatry, 181(5), 393–398.

Feingold, D., Brill, S., Goor-Aryeh, I., Delayahu, Y., & Lev-Ran, S. (2018). The association between severity of depression and prescription opioid misuse among chronic pain patients with and without anxiety: A cross-sectional study. Journal of Affective Disorders, 235, 293–302.

Article  PubMed  Google Scholar 

Forstner, A. J., Awasthi, S., Wolf, C., Maron, E., Erhardt, A., Czamara, D., ... & Schumacher, J. (2021). Genome-wide association study of panic disorder reveals genetic overlap with neuroticism and depression. Molecular psychiatry, 26(8), 4179–4190.

Gage, S. H., & Munafò, M. R. (2015). Rethinking the association between smoking and schizophrenia. The Lancet Psychiatry, 2(2), 118–119.

Article  PubMed  Google Scholar 

Gage, S. H., Bowden, J., Davey Smith, G., & Munafò, M. R. (2018). Investigating causality in associations between education and smoking: A two-sample Mendelian randomization study. International Journal of Epidemiology, 47(4), 1131–1140.

Article  PubMed  PubMed Central  Google Scholar 

Garland, E. L., Froeliger, B., Zeidan, F., Partin, K., & Howard, M. O. (2013). The downward spiral of chronic pain, prescription opioid misuse, and addiction: Cognitive, affective, and neuropsychopharmacologic pathways. Neuroscience & Biobehavioral Reviews, 37(10), 2597–2607.

Article  Google Scholar 

Haack, M., Simpson, N., Sethna, N., Kaur, S., & Mullington, J. (2020). Sleep deficiency and chronic pain: Potential underlying mechanisms and clinical implications. Neuropsychopharmacology, 45(1), 205–216.

Article  PubMed  Google Scholar 

Han, B., Compton, W. M., Jones, C. M., & Cai, R. (2015). Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003–2013. JAMA, 314(14), 1468–1478.

Article  CAS  PubMed  Google Scholar 

Han, B., Jones, C. M., Blanco, C., & Compton, W. M. (2017). National trends in and correlates of nonmedical use of prescription stimulants, nonmedical use frequency, and use disorders. The Journal of Clinical Psychiatry, 78(9), 21718.

Article  Google Scholar 

Hartwell, E. E., Pfeifer, J. G., McCauley, J. L., Moran-Santa Maria, M., & Back, S. E. (2014). Sleep disturbances and pain among individuals with prescription opioid dependence. Addictive Behaviors, 39(10), 1537–1542.

Article  PubMed  PubMed Central  Google Scholar 

Hjorthøj, C., Albert, N., & Nordentoft, M. (2018). Association of substance use disorders with conversion from schizotypal disorder to schizophrenia. JAMA Psychiatry, 75(7), 733–739.

Article  PubMed  PubMed Central  Google Scholar 

Huedo-Medina, T. B., Sánchez-Meca, J., Marín-Martínez, F., & Botella, J. (2006). Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychological Methods, 11(2), 193.

Article  PubMed  Google Scholar 

Jiang, L., Zheng, Z., Fang, H., & Yang, J. (2021). A generalized linear mixed model association tool for biobank-scale data. Nature Genetics, 53(11), 1616–1621.

Article  CAS  PubMed  Google Scholar 

Jones, C. M. (2018). Reprint of trends and key correlates of prescription opioid injection misuse in the United States. Addictive Behaviors, 86, 24–31.

Article  PubMed  Google Scholar 

Jones, C. M., & McCance-Katz, E. F. (2019). Co-occurring substance use and mental disorders among adults with opioid use disorder. Drug and Alcohol Dependence, 197, 78–82.

Article  PubMed  Google Scholar 

Kay, D. C., Pickworth, W. B., & Neider, G. L. (1981). Morphine-like insomnia from heroin in nondependent human addicts. British Journal of Clinical Pharmacology, 11(2), 159–169.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kendler, K. S., Lönn, S. L., Sundquist, J., & Sundquist, K. (2015). Smoking and schizophrenia in population cohorts of Swedish women and men: A prospective co-relative control study. American Journal of Psychiatry, 172(11), 1092–1100.

Article  PubMed  Google Scholar 

Khantzian, E. J. (1997). The self-medication hypothesis of substance use disorders: A reconsideration and recent applications. Harvard Review of Psychiatry, 4(5), 231–244.

Article  CAS  PubMed  Google Scholar 

Ko, J. Y., Patrick, S. W., Tong, V. T., Patel, R., Lind, J. N., & Barfield, W. D. (2016). Incidence of neonatal abstinence syndrome—28 states, 1999–2013. Morbidity and Mortality Weekly Report, 65(31), 799–802.

Article  PubMed  Google Scholar 

Koob, G. F. (2020). Neurobiology of opioid addiction: Opponent process, hyperkatifeia, and negative reinforcement. Biological Psychiatry, 87(1), 44–53.

Article  CAS  PubMed  Google Scholar 

Li, K. J., Chen, A., & DeLisi, L. E. (2020). Opioid use and schizophrenia. Current Opinion in Psychiatry, 33(3), 219–224.

Article  PubMed  Google Scholar 

Moore, J. T., & Kelz, M. B. (2009). Opiates, sleep, and pain: The adenosinergic link. The Journal of the American Society of Anesthesiologists, 111(6), 1175–1176.

Google Scholar 

Morgan, P. T., Pace-Schott, E., Pittman, B., Stickgold, R., & Malison, R. T. (2010). Normalizing effects of modafinil on sleep in chronic cocaine users. American Journal of Psychiatry, 167(3), 331–340.